82: 461-470. 1961 .-Streptomycin-resistant mutants arising spontaneously in pneumococcus vary widely with respect to the maximal concentrations of streptomycin which they resist. A small random sample of these mutations tested for linkage are allelic or closely linked. One single-step mutant resisting a relatively low level of streptomycin undergoes the following changes:
(i) replacement (by a secondary mutation) of the original mutation by an allele conferring a high level of resistance; (ii) reversion to complete sensitivity by back mutation at the originally mutated site; (iii) enhancement by an unlinked modifier gene which confers no resistance by itself but raises the level of resistance of the mutant strain approximately 10-fold. This modifier may have some specificity in its action on the different mutations occurring at a gene locus.
The possibility is discussed that multi-step resistance may often originate by acquisition of modifiers.
The development of resistance to antibiotics in bacteria occurs by several different routes.
Resistance to penicillin, chloramphenicol, or erythromycin, for example, occurs first by mutation conferring resistance to a low concentration of the antibiotic; repeated selection raises the level of resistance to a relatively high concentration of antibiotic (Banic, 1959; Cavalli and Maccacaro, 1952;  Demerec, 1945;  Hotchkiss, 1951;  Ravin and Iyer, 1961) . Recombination between independent first-step mutants also yields cells with a higher level of resistance 1 Present address: Institute of Molecular Biology, University of Oregon, Eugene, Ore. This study was submitted in partial fulfillment of the requirements for the Ph.D. degree. (Banic, 1959;  Cavalli and Maccacaro, 1952;  Ravin and Iyer, 1961) .
Resistance to streptomycin occurs in multil)le steps, but here, the first-step mutations show a much greater variability in the level of resistance which they confer than is shown by first-step mutations for other antibiotics (Demerec, 1948; Hashimoto, 1957; Hotchkiss, 1952; Schaeffer, 1956 ; Watanabe and Watanabe, 1959) . In fact, a high level of resistance to streptomycin, equivalent to that attainable by gradual selection of a multi-step mutant, can be produced in a single step. This study, utilizing transformation techniques, demonstrates that the level of streptomycin resistance can be altered by genetic factors (modifiers) that produce no other detectable effect than to modify the expression of specific loci which directly confer resistance.
MATERIALS AND METHODS
Strains. Strain SIII-1-T50 (Ephrussi-Taylor, 1951a) of pneumococcus was used almost exclusively in these experiments; the capsule-deficient strains R6H and Rz (Ravin, 1959a) were occasionally used.
Genetic markers. The erythromycin resistance marker ery-r2 was used as a control to check the transforming activity of the deoxyribonucleic acid (DNA) preparations and the transformability of recipient strains; it was introduced into the appropriate stocks through the DNA of strain SIII-1-ery-r2 of Ravin. This marker confers resistance to 1 Aug/ml of erythromycin (Ravin and Iyer, 1961 (Ravin, 1959a) . In the second method (Green, 1959) str-r14, str-r25, and str-r26 which resist 3,000, 10,000, and 15,000 ,ug/ml of streptomycin, respectively. Each of these preparations transfers to sensitive cells, in a single transformation event, the level of resistance characteristic of the particular mutant strain. Thus, these three mutants are classified as singlestep mutants, although the levels of antibiotic they resist differ by as much as 5-fold.
Mutation from low single-step resistance to high single-step resistance. The DNA from mutant str-r2, however, produced two classes of resistant transformants, a low-level class characteristic of the donor strain str-r2 (300 ,ug/ml), and a highlevel class resisting 6,000 ,ug/ml of streptomycin. Both classes were approximately equally frequent, although considerably less frequent than cells transformed to the unlinked ery-r2 marker (Table 2, A).
Reexamination of the stock str-r2 culture did not uncover any cells capable of resisting 6,000 ,lg/ml of streptomycin. New transforming preparations from the stock str-r2 culture and from a low-level transformant (obtained by use of the original TP str-r2 on strain SIII-1-T50) were unable to produce any transformants capable of t The str-rl mutation was isolated by Ravin (1956) and was the marker utilized exclusively in experiments reported by him up to the present time. It is a single-step mutant which has been used in this study for comparative purposes. resisting 6,000 ,ug/ml of streptomycin (Table 2, B1, B2). Thus, it seemed likely that a mutation conferring a high level of resistance occurred at the time of growing the str-r2 culture in preparing the original DNA solution; this culture was examined only for cells resistant to 300 ,ug/ml of streptomycin and not for cells resistant to higher concentrations. The culture was lost by cell lysis in the preparation of the DNA, but the high-level transformants produced in strain SIII-1-T50 by the action of this DNA represent its reconstitution.
The reconstituted strain (str-r27) transfers its high level of resistance in a single step as shown by testing its DNA on SIII-1-T50 (Table 2, C). All transformants resist 6,000 ,g/ml of streptomycin.
To determine if the r27 mutation existed in addition to the r2 mutation in the str-r27 strain, or whether it replaced r2, strain str-r2 was treated with TP str-r27 and assayed for resistant cells. The number of resistant cells drops slightly at concentrations above 2,500 ,Ag/ml. As shown later, this drop is explained by mutants in the r2 culture resisting up to 2,500 ,ug/ml of streptomycin. All other transformants grow up to concentrations of 6,000 ,ug/ml of streptomycin. From each of four such experiments a single transformant was picked at random, and a transforming preparation made.
These preparations should show if both the r2 and r27 mutations coexist in the high-level (6, 000 Ag/ml of streptomycin) resistant cell. If they do, these preparations should produce in a sensitive strain a higher number of transformants resisting a low concentration (100 j,g/ml) of streptomycin than transformants resisting a high concentration (>1,000 ,ug/ml); only cells containing the r27 factor should grow at high streptomycin concentrations, whereas cells containing either the r2 or the r27 factor should grow at the low concentration. If they do not coexist in the same cell, only one class of transformants should be produced, namely, transformants capable of resisting high concentrations of streptomycin. Consequently, the number of transformants observed on low and high levels of streptomycin should be the same.
None of the four transforming preparations contain a separable str-r2 factor for there is no detectable difference in counts from 100 to 5,000 ,Ag/ml of streptomycin. Therefore, there is no evidence for the simultaneous presence of the str-r2 and str-r27 factors in the cell line derived by treatment of a str-r2 cell with TP str-r27. However, the two mutations may be very closely linked, at physically close but separate sites of the same transforming agent. If linked the r2 and r27 factors (or their homologues) separate infrequently, less than once in four transformation events.
Linkage of streptomycin-resistance mutations. The demonstration of possible allelism between the str-r2 and str-r27 factors became of great interest when Rotheim (1961) showed that the str-r2 mutation is also either allelic or closely linked to the mutation str-rl (Ravin, 1956 ). The str-rl mutation also confers resistance to 6,000 1961] TP str-r2 ery-r2 #1 is the original TP which produced 2 classes of streptomycin transformants (see text); TP str-r2 ery-r2 #2 came from the stock str-r2 culture, and TP str-r2 ery-r2 #3 from a low-level transformant produced by TP str-r2 ery-r2 #1. TP rev-str-r2 ery-r2 was made from a revertant of strr2 to streptomycin sensitivity. TP str-r2-r$ was made from a high-level transformant obtained by treating str-r2 cells with TP str-rS ery-r2.
* Unless otherwise noted.
Ag/ml of streptomycin. Thus, the phenotypic similarity of the str-r27 and str-rl mutants plus the possible allelism of these two mutations to the str-r2 mutation suggests that the str-r27 and str-rl mutations are identical. In addition Rotheim (1961) showed that the str-rl mutation is allelic or closely linked to the low-level mutation str-r3 which confers resistance to only 150 jig/ml of streptomycin. The possible allelism of these two mutations permitted the prediction that the r3 and r2 factors must also either be allelic or linked. To test this hypothesis, strain str-r3 was treated with TP str-r2 ery-r2, an(d conversely, strain str-r2 was treated with TP str-rS ery-r2. In both experiments, cells were produced which could resist 4,000 ,g/ml of streptomycin. Hence, the r2 and rS mutations are not allelic since they can recombine to produce a higher level of resistance. These two mutations could, however, be linked; in fact, linkage was demonstrated by making transforming preparations from the high-level (4,000 ,g/ml) transformants produced by the interaction of the rS and r2 factors and testing these preparations on sensitive cells. Such preparations transform a sensitive strain primarily to cells resisting no more than 300 ,ug/ml of streptomycin; but for about every 40 of these low-level transformants (r2 and r3 transformants), there is one high-level (double) transformant (Table 2, E) .
Modification by an unlinked factor, en. When testing the stock str-r2 cultures for the presence of the str-r27 factor, another class of streptomycin-resistant cells was detected (as previously noted). This class occurs at an average frequency of 1 X 10-6 cells in all cultures carrying the str-r2 factor, and is resistant to 2,500 /Ag/ml of streptomycin. Cultures tested include single colony isolates from str-r2 strains, independent transformants to the r2 factor in strains SIII-1, R6H, and Rz, and cultures derived from cells which had not been exposed to streptomycin for over 1 year.
This class of cells resisting 2,500 ,ug/ml of streptomycin will henceforth be designated en-str-r2.
DNA was extracted from four independently isolated en-str-r2 mutants and tested on strain SIJI-1-T50. The results are identical to those given by an ordinary TP str-r2 (Table 3) ; that is, more erythromycin-resistant than streptomycinresistant transformants are produced, and almost all of the latter resist only 300 ,Ag/ml of streptomycin. Upon a second round of treatment with a TP en-str-r2, these low-level transformants transform at a high frequency to the 2,500 ,ug/ml level of resistance (Table 4) .
Thus, there are two unlinked factors operating in the en-str-r2 mutants to produce the 2,500 ,ug/ml level of resistance. One of these factors is the original str-r2, and the second factor is en which apparently does not confer any higher resistance than does r2. To determine whether the en factor conferred a lower level of resistance than did r2, transformants were plated at 25 ,ug/ml of streptomycin; this concentration approaches the limiting level at which the recipient SIII-1-T50 strain will grow. All transformants produced by TP en-str-r2 acting on the recipient-sensitive cells are resistant to 300 ,ug/ml of streptomycin, as shown by replication of a large number of transformants. Hence, the second factor, en, does not confer a lower resistance than does the r2 factor.
The possibility still existed that the en factor conferred the same level of resistance as did the r2 mutation. This was tested by treating 100 lowlevel transformants (obtained in independent transformations with TP en-str-r2) with TP str-r2 ery-r2 and assaying for transformation to the 2,500 ,ug/ml level of streptomycin resistance. If any one of the low-level transformants bears the 0.27 1,000 pg/ml 0.8 X 10-7 0.56 X 10-7 <6.4 X 10-7 0.5 X 10-7 <1.4 X 10-7 <5.2 X 10-7 0.42 X 10-7 0.58 X 10-6 <4 X 10-7 <5 X 10-7 <3 X 107 <3 X 107
All transforming preparations were extracted from cells phenotypically resistant to 2,500,ug/ml streptomycin but of the following independent origins: en-i-str-r2 ery-r2 came from a stock str-r2 ery-r2 culture; en-2-str-r2 ery-r2 appeared in an SIII-1 strain previously transformed by the str-r2 factor; en-3-str-r2 ery-r2 was derived from a stock str-r2 culture and subsequently was transformed to erythromycin resistance; en-4-str-r2 ery-r2 came from a culture exposed to streptomycin for a long period and was transformed to erythromycin resistance after isolation. * Unless otherwise noted.
t All colonies replicate to 300 Ag/ml streptomycin.
en factor alone, it should be transformable to the 2,500 ,ug/ml level of resistance by treatment with DNA carrying the r2 factor. Conversely, if a low-level transformant carries the r2 factor, it should be incapable of transforming to a higher level of resistance with TP str-r2. Each of the 100 isolates was transformed by the ery-r2 marker, but not one yielded a higher frequency of high-level resistant cells than did the control tube lacking TP (Table 5 ). There could be preferential incorporation of the str-r2 factor in the first round (which, at the 95% confidence level, would be greater than 20 r2 transformants per en transformant). However, this is contra-lABLE 4. Transformations with TP en-str-r2 on strain str-r2 and on first round transformants 
{<4)<1-02X10
Strain T25-en-2 was derived by transformation of strain SIII-1-T50 with TP en-2-str-r2 ery-r2 and isolation from agar containing 25 jg streptomycin/ml. Strains T100-en-S, T100-en-4, and T100-en-1
were similarly derived by treatment of SIII-1-T50 cells with the corresponding transforming preparations, and isolating transformants from plates containing 100 ug/ml streptomycin. * All strains resist 300 ug/ml streptomycin.
dicted by the fact that, in the second round, the en factor is incorporated just as well, if not better than the ery-r2 factor (Table 4) . The evidence indicates, therefore, that the en factor is not detected in the first round of transformation of strain SIII-1-T50 by TP en-str-r2 because it does not confer resistance but only enhances the action of the r2 factor; since it is unlinked to r2, only rare double transformants (those acquiring both the r2 and en factors) would have the phenotype of en-str-r2.
Specificity of en. To determine whether the en factor is a general enhancer of all mutations to streptomycin resistance at a given locus, experiments were conducted to see if interactions occur between the en factor and the other streptomycin mutations.
Mutant str-r4 (phenotypically identical to mutant str-r2 although of independent origin) shows no interaction with TP str-r2 to produce higher resistance; but it is transformed to a higher level of resistance with any of the four en-str-r2 transforming preparations. The increased level of resistance produced is the same (2,500 Mg/ml of streptomycin) as that obtained with strain str-r2. Thus, in several respects, strain str-r4 mimics strain str-r2, and may represent an independent recurrence of the r2 mutation.
Since the en factor is unlinked to the str-r2 factor, it is technically more feasible to determine if the en factor modifies the r27 or rl mutations by treating en-str-r2 cells with TP str-r27 or TP str-rl. Any transformations by the r27 or ri factor would involve the replacement of the r2 factor but leave the en factor in the recipient cell.
Colonies appearing at concentrations of 4,000
Ag/ml of streptomycin were tested to determine their level of resistance, using str-r27 and str-rl Subscripts of the T100 strains correspond to the particular en-str-r2 TP from which each strain was independently derived in a first round of transformation. Thus, strain T100-en-1-A was isolated from the first experiment in which SIII-1-T50 cells were transformed by TP en-l-str-r2 ery-r2. <3.6 X 10-7 SIll-1 str-s ery-r2-r3 0.22 X 10 6 <1.4 X 10-7 Rx str-s ery-r2-r3-r5 0.84 X 10-5 <1.4 X 107 SIII-1 str-rl ery-r2-r3 0.15 1.0 1.0 * Unless otherwise noted.
t The appearance of transformants resistant to 5,g/ml erythromycin provides a control, showing that the strain is transformable.
t Velvet replication to plates containing 1,000 ,ug/ml streptomycin showed all colonies genetically resistant to at least 1,000 jug/ml streptomycin. strains as controls. The newly transformed cultures grow at concentrations up to 20,000 ,ug/ml of streptomycin, much higher than strains str-r27 or str-rl can grow. Thus, the en factor can enhance the r27 and rl mutations. Rotheim (1961) found that en does not enhance Schaeffer's R2a mutation (Schaeffer, 1956) which is phenotypically similar to str-r2 and closely linked to r3. Hence, en is site specific in its action.
Reversion at the str-r2 site. A stock str-r2 ery-r2 strain, after a routine transfer, was still resistant to erythromycin but not to streptomycin. This revertant (rev-str-r2 ery-r2) was treated with several transforming preparations to determine whether the reversion had occurred at the r2 locus or at a suppressor locus. A DNA preparation carrying the wild-type allele of a suppressor could transform the revertant culture at the suppressor locus, thereby restoring the r2 level of resistance. Conversely, the DNA of the revertant culture, if it carries both the r2 factor and a genetically separable suppressor, should be able to transform a sensitive strain to streptomycin resistance by transfer of the r2 factor.
In all cases, the revertant behaved exactly like the sensitive strain (Table 6) ; it could be transformed to the level of resistance possessed by the DNA donor, and it could not be transformed to streptomycin resistance by DNA from donors lacking a streptomycin resistance mutation. The transformability of the rev-str-r2 ery-r2 strain was shown by transformations with the ery-rS factor (Ravin and Iyer, 1961) . The rev-str-r2 ery-r2 strain could not transform a sensitive strain to streptomycin resistance, although it could transform it to erythromycin resistance (Table 2,  D) .
The reversion in the rev-str-r2 ery-r2 strain apparently occurred at the original str-r2 site, restoring the sensitive condition. Similar studies of reversion at erythromycin loci have also shown reversion at the site of the original mutation (Ravin, 1959b) .
DISCUSSION
From careful examination of a small random sample of spontaneous streptomycin resistance mutations, one obtains a reasonably clear picture of how at least a part of the genetic control of this system operates. All four spontaneous mutations, each of which confers its own characteristic level of resistance, occur at a restricted area of the genome; the streptomycin resistance mutations of Schaeffer (1956) are also localized in this area (Rotheim, 1961) . Of the four mutations, two (str-r2 and str-r3) are at recombinationally separate sites, whereas neither of the other two (s(r-rl and str-r27) recombine with the other three. Therefore, the str-r27 (or -rl) mutation appears to be allelic to both the str-r2 and str-rS mutations. This condition would obtain if the str-r27 (or -rl) mutation extended over the segrrent that included both the r2 and rS sites. The alternative is that the r2, r27 (or -rl), and rS mutations are so closely adjacent, in the order given, that the r27 (or -rl) mutation only infrequently separates from the rS or r2 mutations. These findings are analogous to the results Hotchkiss and Evans (1958) reported for the sulfanilamide region in pneumococcus.
In addition to the mutations directly conferring resistance, one unlinked mutation, en, was found whose only detectable expression is the enhancement of the activity of specific streptomycin resistance mutations.
This study shows that a low-level streptomycin-resistant mutant can acquire a higher level of resistance by three different routes: (i) by recombination with another closely linked mutation; (ii) by mutation to higher resistance at the same, or an overlapping, site; (iii) by enhancement due to the action of a modifier gene arising by mutation. Demerec (1945 Demerec ( , 1948 postulated that the multi-step resistance pattern arises from the action of a polygenic-type system where the differences in the first steps of the streptomycin pattern arise from variations in the potencies of the factors. Polygenes are genetic factors which, as currently defined by geneticists (Darlington and Mather, 1949; Dobzhansky, 1955) , make a small but approximately equal contribution to the total phenotype of the organism. Polygenes may, in higher organisms, be unlinked or show loose linkage as a consequence of being located relatively distantly from each other in the same linkage group; such loose linkage would presumably not show up in the transformation system utilized here, for only restricted portions of the bacterial genome can be examined for linkage, usually only members of the same functional unit. Cavalli and Maccacaro (1952) anticipated that modifier genes might affect resistance, but considered modifier genes to be a special case of polygenic inheritance. By the definition stated above, modifiers would be excluded from the class of polygenes. In polygene inheritance, the level of resistance is raised by acquisition of another mutation which would, by itself, confer a low level of resistance. In the modifier hypothesis, put forward in this paper, there is a primary locus conferring resistance which consists of several recombinable sites, mutations at which could confer similar or different levels of resistance. In addition, there are modifier loci which, by mutation, can enhance the level of resistance conferred by some or all of the sites of the primary locus. By this model, multi-step resistance could be reached by successive mutations within the primary locus, by recombination between mutated sites in the primary locus, or by modification by an unlinked gene of a mutated site in the primary locus. The two hypotheses are contrasted in Fig. 1 .
In the light of the hypothesis, it would be of interest to reexamine some of the reported cases of supposed polygenic inheritance. No positive identification of the factors in multi-step resistance arising by mutation has been made beyond identification of the factors giving first-step resistance. It may well turn out that the modifier hypothesis is correct only for streptomycin resistance and that the polygene model is correct for other systems of antibiotic resistance; or both models may coexist in any given system. Among the four modifier strains isolated, there are no significant differences in their enhancing abilit es, implying that they are at least functionally identical. Nor do the transforming 
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preparations from each strain give increased levels of resistance when tested on the other strains. However, there are differences in their frequencies of transformation of en in the second round of transformation (Table 4) . Two of the preparations (en-2 and en-3) always show nondepressed transformations to high-level streptomycin resistance in the second round, whereas the other pair (en-i and en-4) always show depressed transformations to streptomycin resistance. This fact precludes the immediate assumption that the four isolated enhancing agents are identical. On the other hand, until more is known about the conditions affecting depression of transformation, this difference in frequency of transfer cannot contribute toward differentiating between the enhancer agents.
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